Rapid publication ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway

Diabetes

Volumn 50, Issue 2, 2001, Pages 227-232

  Shintani, Mitsuyo ^a   Ogawa, Yoshihiro ^a   Ebihara, Ken ^a   Aizawa Abe, Megumi ^a   Miyanaga, Fumiko ^a   Takaya, Kazuhiko ^a   Hayashi, Tatsuya ^a   Inoue, Gen ^a   Hosoda, Kiminori ^a   Kojima, Masayasu ^b   Kangawa, Kenji ^b   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APPETITE STIMULANT; GHRELIN; GROWTH HORMONE DERIVATIVE; LEPTIN; LIGAND; MESSENGER RNA; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; UNCLASSIFIED DRUG; GROWTH HORMONE; PEPTIDE; PEPTIDE HORMONE;

ANIMAL EXPERIMENT; ARCUATE NUCLEUS; ARTICLE; DRUG EFFECT; ENERGY METABOLISM; FEEDING BEHAVIOR; FOOD INTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; ANIMAL; DRUG ANTAGONISM; DRUG COMBINATION; GENETICS; HYPOTHALAMUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; PHYSIOLOGY; SECRETION; SPRAGUE DAWLEY RAT;

ANIMALS; DRUG COMBINATIONS; GROWTH HORMONE; HYPOTHALAMUS; INJECTIONS, INTRAVENTRICULAR; LEPTIN; MALE; NEUROPEPTIDE Y; PEPTIDE HORMONES; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0035143816     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.2.227     Document Type: Article

References (53)

1. Growth hormone secretagogues: Physiological role and clinical utility
2. A receptor in pituitary and hypothalamus that functions in growth hormone release
3. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues
4. Molecular cloning and gene expression of growth hormone-releasing peptide receptor in rat tissues
5. Stimulation of growth hormone release from rat pituitary cells by L-692, 429, a novel no-peptidyl GH secretagogue
6. Identification of a pituitary growth hormonereleasing peptide (GHRP) receptor subtype by photoaffinity labeling
7. Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus PHRP-6 in children with neonatal pituitary stalk transection
8. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: Evidence that GHRP-6 main action is exerted at the hypothalamic level
9. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure
10. Growth hormone secretagogues: The clinical future
11. Ghrelin is a growth-hormone-releasing acylated peptide from stomach
12. Intracerebroventricular growth hormone-releasing peptide-6 stimulates eating without affecting plasma growth hormone responses in rats
13. Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats
14. The growth hormone-releasing peptide KP-102 induces c-fos expression in the arcuate nucleus
15. Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release
16. The growth hormone secretagogue KP-102-induced stimulation of food intake is modified by fasting, restraint stress, and somatostatin in rats
17. Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons irt the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6
18. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat
19. Leptin and the regulation of body weight in mammals
20. Unraveling the central nervous system pathway underlying responses to leptin
21. Central nervous system control of food intake
22. Melanocortin receptors in leptin effects
23. Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system
24. Involvement of Agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action
25. The role of neuropeptide Y in the antiobesity action of the obese gene product
26. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y.
27. Alteration of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y.
28. Identification of target of leptin action in rat hypothalamus
29. Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus
30. Transgenic approach to the study of body weight regulation
31. XVI International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors
32. A potent neuropeptide Y antagonist, 1229U91, suppressed spontaneous food intake in Zucker fatty rats
33. Subtype selectivity of the novel nonpeptide neuropeptide YY1 receptor antagonist BIBO3304 and its effect on feeding in rodents
34. The novel neuropeptide YY1 receptor antagonist J-104870: A potent feeding suppressant with oral bioavailability
35. Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor
36. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action
37. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
38. Serum immunoreactive-leptin concentrations in normal-weight and obese humans
39. Feeding inhibition by neuropeptide Y.
40. Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat
41. The weight-reducing effect of an intracerebroventricular bolus injection of leptin in genetically obese fa/fa rats: Reduced sensitivity compared with lean animals
42. Spontaneous dwarf rat
43. Molecular mechanism of growth hormone (GH) deficiency in the spontaneous dwarf rat: Detection of abnormal splicing of GH messenger ribonucleic acid by the polymerase chain reaction
44. Central effect of a novel acylated peptide ghrelin on growth hormone release in rats
45. Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep
46. Stimulation of food intake in rats by centrally administered hypothalamic growth hormone-releasing factor
47. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse
48. Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation
49. Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus
50. A receptor subtype involved in neuropeptide-Y-induced food intake
51. Role of the Y5 neuropeptide Y receptor in feeding and obesity
52. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons